Stockreport

Johnson & Johnson and AbbVie Earn a New FDA Approval for Imbruvica [The Motley Fool]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Imbruvica, a blockbuster cancer drug marketed byJohnson & Johnson(NYSE:JNJAbbVieNYSE:ABBVBiogenNASDAQ:BIIBThis approval was based on positive results from a phase clini [Read more]